Intra-Cellular Therapies Inc. buy RudolfL
Start price
25.01.22
/
60%
€40.53
Target price
30.01.23
€65.00
Performance (%)
10.09%
End price
20.01.23
€44.62
Summary
This prediction ended on 20.01.23 with a price of €44.62. The prediction had a final performance of 10.09%. RudolfL has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by RudolfL for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Buy mit Kursziel 48,0
Kursziel geändert auf 65,0
In the thread Trading Intra-Cellular Therapies Inc.
Buy beendet

